2 studies found for:    Nanoparticle Albumin and einstein
Show Display Options
Rank Status Study
1 Active, not recruiting Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Male Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: paclitaxel;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: ixabepilone;   Biological: bevacizumab;   Other: questionnaire administration;   Other: laboratory biomarker analysis
2 Withdrawn Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Condition: Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Procedure: gene expression analysis;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study;   Procedure: polymerase chain reaction

Indicates status has not been verified in more than two years